Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s Marks Willing To Accept Gene Therapies Occasionally Not Confirming Benefit
Dec 06 2023
•
By
Derrick Gingery
Patients will have to decide whether to accept gene therapy treatment using their own risk tolerance, Marks said. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Cell & Gene Therapies
More from Advanced Technologies